Biologics & Biosimilars
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
1
NLC Health Ventures
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 40%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs Silicozyme B.V.

backs Biodextris
Similar startupsby what they do, their industry and backers

EnteroBiotix is a clinical-stage biopharmaceutical company developing best-in-class full-spectrum microbial therapeutics.

Angiex is developing first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) to address the hallmarks of cancer lethality.

Leading the advancement of biologics for targeted immune regulation & restoration.

Find out more about Biodextris, your premier biologics development and manufacturing partner. Check out our cutting-edge solutions.

About the technology. Optimeos is developing a solution suite to overcome crucial formulation challenges and address unmet medical needs.

Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.

NLC Health Ventures 


